Engineers Gate Manager LP Neurocrine Biosciences Inc Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 76,622 shares of NBIX stock, worth $9.45 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
76,622
Previous 34,644 121.17%
Holding current value
$9.45 Million
Previous $4.77 Million 84.97%
% of portfolio
0.18%
Previous 0.11%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$114.58 - $153.15 $4.81 Million - $6.43 Million
41,978 Added 121.17%
76,622 $8.82 Million
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $2.3 Million - $2.51 Million
17,542 Added 102.57%
34,644 $4.77 Million
Q1 2024

May 15, 2024
BUY
$130.4 - $143.74 $976,304 - $1.08 Million
7,487 Added 77.87%
17,102 $2.36 Million
Q4 2023

Feb 14, 2024
SELL
$106.07 - $132.76 $1.4 Million - $1.75 Million
-13,205 Reduced 57.87%
9,615 $1.27 Million
Q3 2023

Nov 14, 2023
BUY
$94.02 - $117.1 $548,324 - $682,927
5,832 Added 34.33%
22,820 $2.57 Million
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $65,715 - $76,974
-734 Reduced 4.14%
16,988 $1.6 Million
Q1 2023

May 15, 2023
BUY
$94.11 - $123.02 $1.28 Million - $1.68 Million
13,625 Added 332.56%
17,722 $1.79 Million
Q4 2022

Feb 14, 2023
BUY
$106.72 - $127.06 $437,231 - $520,564
4,097 New
4,097 $489,000
Q2 2022

Aug 15, 2022
BUY
$75.79 - $100.07 $116,640 - $154,007
1,539 Added 41.34%
5,262 $513,000
Q1 2022

May 16, 2022
BUY
$72.45 - $94.81 $70,711 - $92,534
976 Added 35.53%
3,723 $349,000
Q4 2021

Feb 14, 2022
SELL
$79.65 - $106.22 $311,351 - $415,213
-3,909 Reduced 58.73%
2,747 $234,000
Q3 2021

Nov 15, 2021
SELL
$86.18 - $99.03 $443,740 - $509,905
-5,149 Reduced 43.62%
6,656 $638,000
Q2 2021

Aug 16, 2021
BUY
$89.43 - $102.27 $1.06 Million - $1.21 Million
11,805 New
11,805 $1.15 Million
Q4 2020

Feb 16, 2021
SELL
$86.91 - $108.33 $1.1 Million - $1.37 Million
-12,618 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$96.16 - $135.15 $863,805 - $1.21 Million
8,983 Added 247.13%
12,618 $1.21 Million
Q2 2020

Aug 17, 2020
BUY
$85.09 - $130.36 $79,048 - $121,104
929 Added 34.33%
3,635 $443,000
Q1 2020

May 15, 2020
SELL
$75.11 - $113.76 $1.61 Million - $2.43 Million
-21,399 Reduced 88.77%
2,706 $234,000
Q4 2019

Feb 14, 2020
BUY
$86.8 - $118.57 $1.62 Million - $2.21 Million
18,635 Added 340.68%
24,105 $2.59 Million
Q3 2019

Nov 14, 2019
BUY
$83.82 - $101.5 $458,495 - $555,205
5,470 New
5,470 $493,000
Q2 2019

Aug 14, 2019
SELL
$72.24 - $91.27 $173,376 - $219,048
-2,400 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$69.31 - $91.53 $166,344 - $219,672
2,400 New
2,400 $211,000

Others Institutions Holding NBIX

# of Institutions
624
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email